Increased Expressions of Matrix Metalloproteinases (MMPs) in Prostate Cancer Tissues of Men with Type 2 Diabetes
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Increased Expressions of Matrix Metalloproteinases (MMPs) in Prostate Cancer Tissues of Men with Type 2 Diabetes
Authors
Keywords
-
Journal
Biomedicines
Volume 8, Issue 11, Pages 507
Publisher
MDPI AG
Online
2020-11-17
DOI
10.3390/biomedicines8110507
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Overall survival and second primary malignancies in men with metastatic prostate cancer
- (2020) Juha Mehtälä et al. PLoS One
- Pre- and Post-diagnosis Diabetes as a Risk Factor for All-Cause and Cancer-Specific Mortality in Breast, Prostate, and Colorectal Cancer Survivors: a Prospective Cohort Study
- (2020) Huan Tao et al. Frontiers in Endocrinology
- CCL2/CCR2 signaling in cancer pathogenesis
- (2020) Qiongyu Hao et al. Cell Communication and Signaling
- A Cautionary Tale: Quantitative LC-HRMS Analytical Procedures for the Analysis of N-Nitrosodimethylamine in Metformin
- (2020) Jingyue Yang et al. AAPS Journal
- Untangling the association between prostate-specific antigen and diabetes: a systematic review and meta-analysis
- (2020) Mari Carmen Bernal-Soriano et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Cytokines and Chemokines as Mediators of Prostate Cancer Metastasis
- (2020) Timothy O. Adekoya et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Human Prostate Cancer Is Characterized by an Increase in Urea Cycle Metabolites
- (2020) Andras Franko et al. Cancers
- Insulin exacerbated high glucose-induced epithelial-mesenchymal transition in prostatic epithelial cells BPH-1 and prostate cancer cells PC-3 via MEK/ERK signaling pathway
- (2020) Tingting Yang et al. EXPERIMENTAL CELL RESEARCH
- Characterization of Hormone-Dependent Pathways in Six Human Prostate-Cancer Cell Lines: A Gene-Expression Study
- (2020) Andras Franko et al. Genes
- Transcript Levels of Aldo-Keto Reductase Family 1 Subfamily C (AKR1C) Are Increased in Prostate Tissue of Patients with Type 2 Diabetes
- (2020) Andras Franko et al. Journal of Personalized Medicine
- The anticancer potential of metformin on prostate cancer
- (2019) Saher Zaidi et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Blood glucose, glucose balance, and disease-specific survival after prostate cancer diagnosis in the Finnish Randomized Study of Screening for Prostate Cancer
- (2019) Teemu J. Murtola et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Serum protein signature of coronary artery disease in type 2 diabetes mellitus
- (2019) Ramu Adela et al. Journal of Translational Medicine
- Poorly controlled diabetes increases the risk of metastases and castration‐resistant prostate cancer in men undergoing radical prostatectomy: Results from the SEARCH database
- (2019) Farnoosh Nik‐Ahd et al. CANCER
- Use of metformin and outcome of patients with newly diagnosed glioblastoma: Pooled analysis
- (2019) Corinna Seliger et al. INTERNATIONAL JOURNAL OF CANCER
- Hyperglycemia and T Cell infiltration are associated with stromal and epithelial prostatic hyperplasia in the nonobese diabetic mouse
- (2019) LaTayia M. Aaron‐Brooks et al. PROSTATE
- The multifaceted effects of metformin on tumor microenvironment
- (2019) Ivana Kurelac et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- What role do fat cells play in pancreatic tissue?
- (2019) Felicia Gerst et al. Molecular Metabolism
- Suppressive Role of Androgen/Androgen Receptor Signaling via Chemokines on Prostate Cancer Cells
- (2019) Kouji Izumi et al. Journal of Clinical Medicine
- Metalloproteinases mediate diabetes-induced retinal neuropathy and vasculopathy
- (2019) Ghislain Opdenakker et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Prostate Cancer
- (2019) Aradhana Rani et al. AMERICAN JOURNAL OF PATHOLOGY
- Epithelial mesenchymal transition and resistance in endocrine-related cancers
- (2019) Zoran Culig BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Matrix Metalloproteases as Influencers of the Cells’ Social Media
- (2019) Daniel Young et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- ALPK1 regulates streptozotocin‐induced nephropathy through CCL2 and CCL5 expressions
- (2019) Chi‐Pin Lee et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- A phase II randomized clinical trial of the effect of metformin versus placebo on progression-free survival in women with metastatic breast cancer receiving standard chemotherapy
- (2019) Isabel Pimentel et al. BREAST
- Higher prevalence of lymph node metastasis in prostate cancer in patients with diabetes
- (2018) Stefan Zoltán Lutz et al. ENDOCRINE-RELATED CANCER
- Metformin Use Is Associated with Improved Survival in Patients with Advanced Prostate Cancer on Androgen Deprivation Therapy
- (2018) Kyle A. Richards et al. JOURNAL OF UROLOGY
- Glucose impairments and insulin resistance in prostate cancer: the role of obesity, nutrition and exercise
- (2018) K. M. Di Sebastiano et al. Obesity Reviews
- cGMP-dependent protein kinase I (cGKI) modulates human hepatic stellate cell activation
- (2018) Andras Franko et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Hyperglycemia, Classified with Multiple Biomarkers Simultaneously in Men without Diabetes, and Risk of Fatal Prostate Cancer
- (2018) Michael T. Marrone et al. Cancer Prevention Research
- Epithelial-mesenchymal transition in prostate cancer: an overview
- (2017) Micaela Montanari et al. Oncotarget
- Bezafibrate Improves Insulin Sensitivity and Metabolic Flexibility in STZ-Induced Diabetic Mice
- (2016) Andras Franko et al. DIABETES
- Tissue invasion and metastasis: Molecular, biological and clinical perspectives
- (2015) W.G. Jiang et al. SEMINARS IN CANCER BIOLOGY
- Type 2 diabetes and the risk of mortality among patients with prostate cancer
- (2014) Leah Bensimon et al. CANCER CAUSES & CONTROL
- Diabetes mellitus is associated with elevated risk of mortality amongst patients with prostate cancer: a meta-analysis of 11 cohort studies
- (2014) Hongzhou Cai et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Missing the target: matrix metalloproteinase antitargets in inflammation and cancer
- (2013) Antoine Dufour et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Type 2 diabetes and risk of prostate cancer: a meta-analysis of observational studies
- (2012) D Bansal et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Metformin Accelerates the Growth of BRAF V600E -Driven Melanoma by Upregulating VEGF-A
- (2012) Matthew J. Martin et al. Cancer Discovery
- Biochemical Analysis of Matrix Metalloproteinase Activation of Chemokines CCL15 and CCL23 and Increased Glycosaminoglycan Binding of CCL16
- (2011) Amanda E. Starr et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Glycemic control and prostate cancer progression: Results from the SEARCH database
- (2010) Howard S. Kim et al. PROSTATE
- CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis
- (2009) Jian Zhang et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Molecular pathways mediating the anti-inflammatory effects of calcitriol: implications for prostate cancer chemoprevention and treatment
- (2009) Aruna V Krishnan et al. ENDOCRINE-RELATED CANCER
- Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERα negative MDA-MB-435 breast cancer model
- (2008) Kathryn N. Phoenix et al. BREAST CANCER RESEARCH AND TREATMENT
- Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study
- (2008) Jocelyn S. Kasper et al. INTERNATIONAL JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now